HCPCS Level II
J7190
Factor viii (antihemophilic factor, human) per i.u.
Codes near J7190
These sit next to J7190 in the CMS Level II file. All J codes
- J7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
- J7186Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
- J7187Injection, von willebrand factor complex (humate-p), per iu vwf:rco
- J7188Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
- J7189Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
- J7191Factor viii (antihemophilic factor (porcine)), per i.u.
- J7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
- J7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
- J7194Factor ix, complex, per i.u.
- J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00944-3940-02 | Hemofil M | Takeda Pharmaceuticals America, Inc. | 1 |
| 00944-3942-02 | Hemofil M | Takeda Pharmaceuticals America, Inc. | 1 |
| 00944-3944-02 | Hemofil M | Takeda Pharmaceuticals America, Inc. | 1 |
| 00944-3946-02 | Hemofil M | Takeda Pharmaceuticals America, Inc. | 1 |
| 76125-0257-25 | Koate | Kedrion Biopharma Inc | 1 |
| 76125-0663-50 | Koate | Kedrion Biopharma Inc | 1 |
| 76125-0679-12 | Koate | Kedrion Biopharma Inc | 1 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.